Both in Biotechnology
Kymera Therapeutics vs ImmunityBio
Over the past year KYMR returned +88.9% and IBRX returned +243.6%; their daily moves had a correlation of 0.14.
KYMR +88.9% IBRX +243.6%Growth of $1, one year, split-adjusted
| Metric | KYMR | IBRX |
|---|---|---|
| Price | $110.51 | $8.83 |
| Market cap | $9.19B | $9.36B |
| Today | −1.33% | +3.64% |
| 1 month | −6.5% | +9.7% |
| 6 months | +39.0% | +32.6% |
| Year to date | +42.0% | +346.0% |
| 1 year | +96.5% | +247.6% |
| Revenue growth (YoY) | +466.4% | +93.9% |
| Gross margin | 100.0% | 99.4% |
| Net margin | −94.2% | −449.6% |
| P/E (TTM) | — | — |
| Price / sales | 87.5× | 56.4× |
| Net cash | $688.6M | -$57.7M |
| Dividend yield | — | — |
| Volatility (60d) | 41.5% | 60.5% |
| Short % of float | 17.7% | 31.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).